These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30488079)

  • 1. Effects of proton pump inhibitor on the human gut microbiome profile in multi-ethnic groups in Singapore.
    Koo SH; Deng J; Ang DSW; Hsiang JC; Lee LS; Aazmi S; Mohamed EHM; Yang H; Yap SY; Teh LK; Salleh MZ; Lee EJD; Ang TL
    Singapore Med J; 2019 Oct; 60(10):512-521. PubMed ID: 30488079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral microbiome alterations of healthy volunteers with proton pump inhibitor.
    Mishiro T; Oka K; Kuroki Y; Takahashi M; Tatsumi K; Saitoh T; Tobita H; Ishimura N; Sato S; Ishihara S; Sekine J; Wada K; Kinoshita Y
    J Gastroenterol Hepatol; 2018 May; 33(5):1059-1066. PubMed ID: 29105152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of omeprazole treatment on the gut microflora and neutrophil function.
    Kostrzewska M; Świdnicka-Siergiejko A; Olszańska D; Jurkowska G; Garley M; Ratajczak-Wrona W; Jabłońska E; Jamiołkowski J; Dabrowski A
    Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):575-584. PubMed ID: 28258834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Proton Pump Inhibitors on the Small Bowel and Stool Microbiomes.
    Weitsman S; Celly S; Leite G; Mathur R; Sedighi R; Barlow GM; Morales W; Sanchez M; Parodi G; Villanueva-Millan MJ; Rezaie A; Pimentel M
    Dig Dis Sci; 2022 Jan; 67(1):224-232. PubMed ID: 33534012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Proton Pump Inhibitor Administration Caused Physiological and Microbiota Changes in Rats.
    Yang YSH; Chang HW; Lin IH; Chien LN; Wu MJ; Liu YR; Chu PG; Xie G; Dong F; Jia W; Chang VHS; Yen Y
    Sci Rep; 2020 Jan; 10(1):866. PubMed ID: 31964941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A Prospective Longitudinal Interventional Study.
    Castellani C; Singer G; Kashofer K; Huber-Zeyringer A; Flucher C; Kaiser M; Till H
    Front Cell Infect Microbiol; 2017; 7():444. PubMed ID: 29075620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors affect the gut microbiome.
    Imhann F; Bonder MJ; Vich Vila A; Fu J; Mujagic Z; Vork L; Tigchelaar EF; Jankipersadsing SA; Cenit MC; Harmsen HJ; Dijkstra G; Franke L; Xavier RJ; Jonkers D; Wijmenga C; Weersma RK; Zhernakova A
    Gut; 2016 May; 65(5):740-8. PubMed ID: 26657899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract-evidence from next-generation sequencing studies.
    Macke L; Schulz C; Koletzko L; Malfertheiner P
    Aliment Pharmacol Ther; 2020 Mar; 51(5):505-526. PubMed ID: 31990420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Proton Pump Inhibitor Omeprazole Does Not Promote Clostridioides difficile Colonization in a Murine Model.
    Tomkovich S; Lesniak NA; Li Y; Bishop L; Fitzgerald MJ; Schloss PD
    mSphere; 2019 Nov; 4(6):. PubMed ID: 31748246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compared to histamine-2 receptor antagonist, proton pump inhibitor induces stronger oral-to-gut microbial transmission and gut microbiome alterations: a randomised controlled trial.
    Zhu J; Sun C; Li M; Hu G; Zhao XM; Chen WH
    Gut; 2024 Jun; 73(7):1087-1097. PubMed ID: 38050061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the gut microbiome between long-term users and non-users of proton pump inhibitors.
    Clooney AG; Bernstein CN; Leslie WD; Vagianos K; Sargent M; Laserna-Mendieta EJ; Claesson MJ; Targownik LE
    Aliment Pharmacol Ther; 2016 May; 43(9):974-84. PubMed ID: 26923470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of proton pump inhibitors on microbiota in chronic liver disease patients.
    Yamamoto K; Ishigami M; Honda T; Takeyama T; Ito T; Ishizu Y; Kuzuya T; Hayashi K; Goto H; Hirooka Y
    Hepatol Int; 2019 Mar; 13(2):234-244. PubMed ID: 30737678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celiac disease serology and gut microbiome following proton pump inhibitor treatment.
    Jang S; Lebwohl B; Abrams JA; Green PHR; Freedberg DE; Alaedini A
    Medicine (Baltimore); 2020 Aug; 99(35):e21488. PubMed ID: 32871870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors alter gut microbiota by promoting oral microbiota translocation: a prospective interventional study.
    Xiao X; Zhang X; Wang J; Liu Y; Yan H; Xing X; Yang J
    Gut; 2024 Jun; 73(7):1098-1109. PubMed ID: 38267200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the proton pump inhibitor omeprazole on the gastrointestinal bacterial microbiota of healthy dogs.
    Garcia-Mazcorro JF; Suchodolski JS; Jones KR; Clark-Price SC; Dowd SE; Minamoto Y; Markel M; Steiner JM; Dossin O
    FEMS Microbiol Ecol; 2012 Jun; 80(3):624-36. PubMed ID: 22324305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of proton pump inhibitor or rebamipide use on gut microbiota of rheumatoid arthritis patients.
    Kim JW; Jeong Y; Park SJ; Jin H; Lee J; Ju JH; Ji GE; Park SH
    Rheumatology (Oxford); 2021 Feb; 60(2):708-716. PubMed ID: 32789440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial.
    Freedberg DE; Toussaint NC; Chen SP; Ratner AJ; Whittier S; Wang TC; Wang HH; Abrams JA
    Gastroenterology; 2015 Oct; 149(4):883-5.e9. PubMed ID: 26164495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients.
    Paroni Sterbini F; Palladini A; Masucci L; Cannistraci CV; Pastorino R; Ianiro G; Bugli F; Martini C; Ricciardi W; Gasbarrini A; Sanguinetti M; Cammarota G; Posteraro B
    Appl Environ Microbiol; 2016 Nov; 82(22):6633-6644. PubMed ID: 27590821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low gut microbiota diversity and dietary magnesium intake are associated with the development of PPI-induced hypomagnesemia.
    Gommers LMM; Ederveen THA; van der Wijst J; Overmars-Bos C; Kortman GAM; Boekhorst J; Bindels RJM; de Baaij JHF; Hoenderop JGJ
    FASEB J; 2019 Oct; 33(10):11235-11246. PubMed ID: 31299175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.